Literature DB >> 18184709

Clonogenic assay of type a influenza viruses reveals noninfectious cell-killing (apoptosis-inducing) particles.

John M Ngunjiri1, Margaret J Sekellick, Philip I Marcus.   

Abstract

Clonogenic (single-cell plating) assays were used to define and quantify subpopulations of two genetically closely related variants of influenza virus A/TK/OR/71 that differed primarily in the size of the NS1 gene product; they expressed a full-size (amino acids [aa] 1 to 230) or truncated (aa 1 to 124) NS1 protein. Monolayers of Vero cells were infected with different amounts of virus, monodispersed, and plated. Cell survival curves were generated from the fraction of cells that produced visible colonies as a function of virus multiplicity. The exponential loss of colony-forming capacity at low multiplicities demonstrated that a single virus particle sufficed to kill a cell. The ratios of cell-killing particles (CKP) to plaque-forming particles (PFP) were 1:1 and 7:1 in populations of variants NS1(1-124) and NS1(1-230), respectively. This study revealed a new class of particles in influenza virus populations-noninfectious CKP. Both infectious and noninfectious CKP were 6.3 times more resistant to UV radiation than PFP activity. Based on UV target theory, a functional polymerase subunit was implicated in a rate-limiting step in cell killing. Since influenza viruses kill cells by apoptosis (programmed cell death), CKP are functionally apoptosis-inducing particles. Noninfectious CKP are present in excess of PFP in virus populations with full-size NS1 and induce apoptosis that is temporally delayed and morphologically different than that initiated by infectious CKP present in the virus population expressing truncated NS1. The identification and quantification of both infectious and noninfectious CKP defines new phenotypes in influenza virus populations and presents a challenge to determine their role in regulating infectivity, pathogenesis, and vaccine efficacy.

Entities:  

Mesh:

Year:  2008        PMID: 18184709      PMCID: PMC2258965          DOI: 10.1128/JVI.02221-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Cell killing by viruses. II. Cell killing by vesicular stomatitis virus: a requirement for virion-derived transcription.

Authors:  P I Marcus; M J Sekellick
Journal:  Virology       Date:  1975-01       Impact factor: 3.616

2.  Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses.

Authors:  Christina Ehrhardt; Thorsten Wolff; Stephan Pleschka; Oliver Planz; Wiebke Beermann; Johannes G Bode; Mirco Schmolke; Stephan Ludwig
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  Cell killing by viruses. I. Comparison of cell-killing, plaque-forming, and defective-interfering particles of vesicular stomatitis virus.

Authors:  P I Marcus; M J Sekellick
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

4.  Plaque formation by influenza viruses in the presence of trypsin.

Authors:  G Appleyard; H B Maber
Journal:  J Gen Virol       Date:  1974-12       Impact factor: 3.891

5.  A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis.

Authors:  Ji-Young Min; Shoudong Li; Ganes C Sen; Robert M Krug
Journal:  Virology       Date:  2007-02-22       Impact factor: 3.616

6.  Interferon induction and/or production and its suppression by influenza A viruses.

Authors:  Philip I Marcus; Jillian M Rojek; Margaret J Sekellick
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  Interferon induction as a quasispecies marker of vesicular stomatitis virus populations.

Authors:  P I Marcus; L L Rodriguez; M J Sekellick
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

8.  Infectious influenza A and B virus variants with long carboxyl terminal deletions in the NS1 polypeptides.

Authors:  G P Norton; T Tanaka; K Tobita; S Nakada; D A Buonagurio; D Greenspan; M Krystal; P Palese
Journal:  Virology       Date:  1987-02       Impact factor: 3.616

9.  Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling.

Authors:  Oleg P Zhirnov; Hans-Dieter Klenk
Journal:  Apoptosis       Date:  2007-08       Impact factor: 4.677

Review 10.  Influenza virus induction of apoptosis by intrinsic and extrinsic mechanisms.

Authors:  R Joel Lowy
Journal:  Int Rev Immunol       Date:  2003 Sep-Dec       Impact factor: 5.311

View more
  12 in total

1.  In vitro analysis of virus particle subpopulations in candidate live-attenuated influenza vaccines distinguishes effective from ineffective vaccines.

Authors:  Philip I Marcus; John M Ngunjiri; Margaret J Sekellick; Leyi Wang; Chang-Won Lee
Journal:  J Virol       Date:  2010-08-25       Impact factor: 5.103

2.  Dynamics of biologically active subpopulations of influenza virus: plaque-forming, noninfectious cell-killing, and defective interfering particles.

Authors:  Philip I Marcus; John M Ngunjiri; Margaret J Sekellick
Journal:  J Virol       Date:  2009-06-03       Impact factor: 5.103

3.  Biological activities of 'noninfectious' influenza A virus particles.

Authors:  Christopher B Brooke
Journal:  Future Virol       Date:  2014-01       Impact factor: 1.831

4.  Higher titers of some H5N1 and recent human H1N1 and H3N2 influenza viruses in Mv1 Lu vs. MDCK cells.

Authors:  Sara B Hamilton; Diane E Wyatt; Brett T Wahlgren; Maureen K O'Dowd; Jane M Morrissey; Deirdre E Daniels; John A Lednicky
Journal:  Virol J       Date:  2011-02-11       Impact factor: 4.099

Review 5.  Population Diversity and Collective Interactions during Influenza Virus Infection.

Authors:  Christopher B Brooke
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

6.  Most influenza a virions fail to express at least one essential viral protein.

Authors:  Christopher B Brooke; William L Ince; Jens Wrammert; Rafi Ahmed; Patrick C Wilson; Jack R Bennink; Jonathan W Yewdell
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

7.  Transmission of aerosolized seasonal H1N1 influenza A to ferrets.

Authors:  Heather MacInnes; Yue Zhou; Kristine Gouveia; Jenna Cromwell; Kristin Lowery; R Colby Layton; Michael Zubelewicz; Rangarajan Sampath; Steven Hofstadler; Yushi Liu; Yung-Sung Cheng; Frederick Koster
Journal:  PLoS One       Date:  2011-09-19       Impact factor: 3.240

8.  Exhaled aerosol transmission of pandemic and seasonal H1N1 influenza viruses in the ferret.

Authors:  Frederick Koster; Kristine Gouveia; Yue Zhou; Kristin Lowery; Robert Russell; Heather MacInnes; Zemmie Pollock; R Colby Layton; Jennifer Cromwell; Denise Toleno; John Pyle; Michael Zubelewicz; Kevin Harrod; Rangarajan Sampath; Steven Hofstadler; Peng Gao; Yushi Liu; Yung-Sung Cheng
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

9.  Serum-Free Suspension Culture of MDCK Cells for Production of Influenza H1N1 Vaccines.

Authors:  Ding Huang; Wen-Juan Peng; Qian Ye; Xu-Ping Liu; Liang Zhao; Li Fan; Kang Xia-Hou; Han-Jing Jia; Jian Luo; Lin-Ting Zhou; Bei-Bei Li; Shi-Lei Wang; Wen-Ting Xu; Ze Chen; Wen-Song Tan
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

10.  Antibody-free digital influenza virus counting based on neuraminidase activity.

Authors:  Kazuhito V Tabata; Yoshihiro Minagawa; Yuko Kawaguchi; Mana Ono; Yoshiki Moriizumi; Seiya Yamayoshi; Yoichiro Fujioka; Yusuke Ohba; Yoshihiro Kawaoka; Hiroyuki Noji
Journal:  Sci Rep       Date:  2019-01-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.